MEI Retained Earnings Total Equity vs Property Plant And Equipment Gross Analysis
MEIP Stock | USD 2.43 0.03 1.22% |
MEI Pharma financial indicator trend analysis is infinitely more than just investigating MEI Pharma recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether MEI Pharma is a good investment. Please check the relationship between MEI Pharma Retained Earnings Total Equity and its Property Plant And Equipment Gross accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEI Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in MEI Stock, please use our How to Invest in MEI Pharma guide.
Retained Earnings Total Equity vs Property Plant And Equipment Gross
Retained Earnings Total Equity vs Property Plant And Equipment Gross Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of MEI Pharma Retained Earnings Total Equity account and Property Plant And Equipment Gross. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between MEI Pharma's Retained Earnings Total Equity and Property Plant And Equipment Gross is -0.69. Overlapping area represents the amount of variation of Retained Earnings Total Equity that can explain the historical movement of Property Plant And Equipment Gross in the same time period over historical financial statements of MEI Pharma, assuming nothing else is changed. The correlation between historical values of MEI Pharma's Retained Earnings Total Equity and Property Plant And Equipment Gross is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Retained Earnings Total Equity of MEI Pharma are associated (or correlated) with its Property Plant And Equipment Gross. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Property Plant And Equipment Gross has no effect on the direction of Retained Earnings Total Equity i.e., MEI Pharma's Retained Earnings Total Equity and Property Plant And Equipment Gross go up and down completely randomly.
Correlation Coefficient | -0.69 |
Relationship Direction | Negative |
Relationship Strength | Weak |
Retained Earnings Total Equity
The portion of total equity that consists of earnings retained by the company, reinvested in its core business or used to pay debt.Property Plant And Equipment Gross
Most indicators from MEI Pharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into MEI Pharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEI Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in MEI Stock, please use our How to Invest in MEI Pharma guide.At this time, MEI Pharma's Selling General Administrative is relatively stable compared to the past year. As of 03/05/2025, Enterprise Value Over EBITDA is likely to grow to 0.55, while Sales General And Administrative To Revenue is likely to drop 0.39.
MEI Pharma fundamental ratios Correlations
Click cells to compare fundamentals
MEI Pharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
MEI Pharma fundamental ratios Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Assets | 174.1M | 177.8M | 120.8M | 41.4M | 47.6M | 62.7M | |
Other Current Liab | 7.5M | 9.9M | 11.0M | 5.2M | 6.0M | 3.9M | |
Total Current Liabilities | 30.3M | 24.4M | 20.3M | 8.4M | 9.6M | 8.3M | |
Total Stockholder Equity | 41.4M | 52.4M | 24.6M | 33.0M | 38.0M | 32.7M | |
Net Debt | (245K) | (6.1M) | (4.2M) | (3.7M) | (4.3M) | (4.5M) | |
Accounts Payable | 6.4M | 7.9M | 6.1M | 3.2M | 3.6M | 2.2M | |
Cash | 8.5M | 15.7M | 16.9M | 3.7M | 3.3M | 3.2M | |
Cash And Short Term Investments | 153.4M | 153.3M | 100.7M | 38.3M | 44.1M | 57.3M | |
Common Stock Shares Outstanding | 5.7M | 6.3M | 6.7M | 6.7M | 7.7M | 8.0M | |
Liabilities And Stockholders Equity | 174.1M | 177.8M | 120.8M | 41.4M | 47.6M | 62.7M | |
Other Current Assets | 3.8M | 7.7M | 11.3M | 2.4M | 2.8M | 1.9M | |
Other Stockholder Equity | 369.2M | 426.6M | 430.6M | 421.2M | 484.4M | 508.6M | |
Total Liab | 132.7M | 125.4M | 96.2M | 8.4M | 9.6M | 9.1M | |
Total Current Assets | 164.8M | 167.1M | 107.5M | 40.8M | 46.9M | 60.9M | |
Retained Earnings | (327.8M) | (374.2M) | (406.0M) | (388.2M) | (349.4M) | (331.9M) | |
Short Term Investments | 144.9M | 137.5M | 83.8M | 34.6M | 39.8M | 70.4M | |
Property Plant And Equipment Net | 9.3M | 10.7M | 13.3M | 606K | 696.9K | 662.1K | |
Non Current Assets Total | 9.3M | 10.7M | 13.3M | 606K | 696.9K | 662.1K | |
Property Plant And Equipment Gross | 9.3M | 11.4M | 14.3M | 2.4M | 2.7M | 2.9M | |
Property Plant Equipment | 1.1M | 9.3M | 10.7M | 13.3M | 15.3M | 16.0M | |
Net Tangible Assets | 78.2M | 41.4M | 52.4M | 24.6M | 28.3M | 48.6M | |
Non Currrent Assets Other | (1.1M) | (9.3M) | (10.7M) | (13.3M) | (12.0M) | (11.4M) | |
Current Deferred Revenue | 14.8M | 14.6M | 4.8M | 317K | 364.6K | 346.3K | |
Net Invested Capital | 41.4M | 52.4M | 24.6M | 33.0M | 29.7M | 37.9M | |
Net Working Capital | 134.5M | 142.7M | 87.2M | 32.4M | 37.3M | 35.4M | |
Other Liab | 108.2M | 95.1M | 92.2M | 64.5M | 74.2M | 78.2M | |
Net Receivables | 20.4M | 7.6M | 10.0M | 85K | 76.5K | 72.7K |
Additional Tools for MEI Stock Analysis
When running MEI Pharma's price analysis, check to measure MEI Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEI Pharma is operating at the current time. Most of MEI Pharma's value examination focuses on studying past and present price action to predict the probability of MEI Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEI Pharma's price. Additionally, you may evaluate how the addition of MEI Pharma to your portfolios can decrease your overall portfolio volatility.